ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,433.76
0.63%
Dow Jones
39,512.84
0.32%
Gold vs US Dollar
2,360.48
0.58%
Brent Oil
82.585
-1.63%
Bitcoin
60,625.75
-3.84%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Geron Corp (GERN)

  7. Geron Corp (GERN) News

Geron (GERN)

Geron Corp
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GERN
DateTimeSourceHeadlineSymbolCompany
02/05/202412:00Business WireGeron Corporation Reports First Quarter 2024 Financial Results and Business HighlightsNASDAQ:GERNGeron Corp
25/04/202421:30Business WireGeron to Announce First Quarter 2024 Financial Results on May 2, 2024NASDAQ:GERNGeron Corp
18/04/202421:30Business WireGeron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GERNGeron Corp
03/04/202421:30Business WireGeron to Participate at Upcoming Investor Conferences in AprilNASDAQ:GERNGeron Corp
19/03/202413:07Business WireGeron Corporation Announces Pricing of $150 Million Underwritten Offering of Common Stock and Pre-Funded WarrantsNASDAQ:GERNGeron Corp
14/03/202419:54Business WireGeron Announces FDA Oncologic Drugs Advisory Committee Votes in Favor of the Clinical Benefit/Risk Profile of Imetelstat for the Treatment of Transfusion-Dependent Anemia in Patients with Lower-Risk MDSNASDAQ:GERNGeron Corp
28/02/202412:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GERNGeron Corp
28/02/202412:05Business WireGeron Corporation Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:GERNGeron Corp
22/02/202421:30Business WireGeron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GERNGeron Corp
16/02/202421:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GERNGeron Corp
16/02/202421:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GERNGeron Corp
16/02/202421:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GERNGeron Corp
16/02/202421:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GERNGeron Corp
16/02/202421:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GERNGeron Corp
16/02/202421:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GERNGeron Corp
14/02/202422:01Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:GERNGeron Corp
14/02/202421:30Business WireGeron to Announce Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024NASDAQ:GERNGeron Corp
14/02/202413:44Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:GERNGeron Corp
30/01/202413:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GERNGeron Corp
26/01/202416:49Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:GERNGeron Corp
18/01/202421:30Business WireGeron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GERNGeron Corp
12/01/202413:30Business WireGeron to Participate in the B. Riley Securities Virtual Oncology ConferenceNASDAQ:GERNGeron Corp
08/01/202413:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GERNGeron Corp
04/01/202400:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GERNGeron Corp
04/01/202400:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GERNGeron Corp
04/01/202400:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GERNGeron Corp
21/12/202321:30Business WireGeron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GERNGeron Corp
15/12/202321:23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GERNGeron Corp
11/12/202321:15Business WireGeron Announces IMerge Phase 3 Presentations at ASH Highlighting Significant Durability of Transfusion Independence and Breadth of Effect Across MDS Subgroups with Imetelstat in Lower Risk MDSNASDAQ:GERNGeron Corp
06/12/202313:00Business WireGeron Announces Fifty Percent Enrollment in the Phase 3 IMpactMF Clinical Trial Evaluating Imetelstat in Patients with Relapsed/Refractory MyelofibrosisNASDAQ:GERNGeron Corp
 Showing the most relevant articles for your search:NASDAQ:GERN

Your Recent History

LSE
POS
Plexus
LSE
TERN
Tern
LSE
SYME
Supply@me Capital
LSE
PET
Petrel Resources
LSE
AAZ
Anglo Asian Mining
LSE
ITV
Itv
LSE
SFOR
S4 Capital
LSE
RR.
Rolls-royce
LSE
THG
Thg
LSE
PANR
Pantheon Resources
LSE
AGL
Angle
LSE
BOO
Boohoo
LSE
POLX
Polarean Imaging
LSE
TXP
Touchstone Exploration
LSE
LLOY
Lloyds Banking
LSE
GKP
Gulf Keystone Petroleum
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved